Developing c-MET pathway inhibitors for cancer therapy: progress and challenges: Trends in Molecular Medicine
c-Met inhibitor 1 TM-T10655 | CymitQuimica
c-Met inhibitor 1 | c-Met/HGFR Inhibitor | MedChemExpress
Recent advances in the discovery of small molecule c-Met Kinase inhibitors - ScienceDirect
c-Met inhibitor 2
Development of antibody-based c-Met inhibitors for targeted cancer the | ITT
Frontiers | The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma | Cell and Developmental Biology
c-Met inhibitor - Wikipedia
Type II c-Met inhibitors: molecular insight into crucial interactions for effective inhibition | SpringerLink
A DNA aptamer to c-Met inhibits cancer cell migration - Chemical Communications (RSC Publishing) DOI:10.1039/C4CC06016D
![PDF] EGFR and c-Met Inhibitors are Effective in Reducing Tumorigenicity in Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fb34e0b378ab283ee885fb912c61cc28ae8a288b/3-Figure1-1.png "PDF] EGFR and c-Met Inhibitors are Effective in Reducing Tumorigenicity in Cancer | Semantic Scholar")
PDF] EGFR and c-Met Inhibitors are Effective in Reducing Tumorigenicity in Cancer | Semantic Scholar
Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer | Molecular Cancer | Full Text
c-Met inhibitor - Wikiwand
Pathway activation mapping of c-MET inhibitor effects in high-and... | Download Scientific Diagram
Capmatinib cancer drug molecule (c-met inhibitor). 3D rendering. Atoms are represented as spheres with conventional color coding: hydrogen (white), ca Stock Photo - Alamy
The role of MET in chemotherapy resistance | Oncogene
AMG-458 is a Selective and Orally Bioavailable c-Met Inhibitor - Network of Cancer Research
Therapeutic targeting of HGF/c-Met pathway. c-Met pathway inhibition... | Download Scientific Diagram
BPI-9016M is an Orally Active and Selective Dual c-Met/AXL Inhibitor - Network of Cancer Research
PLOS ONE: The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma
Frontiers | Targeting the HGF/MET Axis in Cancer Therapy: Challenges in Resistance and Opportunities for Improvement | Cell and Developmental Biology
c-Met inhibitor - Wikipedia
Safety and Tolerability of c-MET Inhibitors in Cancer | SpringerLink
Classification of HGF/c-MET Inhibitors. | Download Table
c-Met Inhibitors with Novel Binding Mode Show Activity against Several Hereditary Papillary Renal Cell Carcinoma-related Mutations* - Journal of Biological Chemistry
